David Lieberman, MD
This content is PDF only. Please click on the PDF icon to access.
To the Editor: Allison and associates (1) evaluated the sensitivity of fecal occult blood tests in detecting colorectal neoplasms. The 50% sensitivity they found at 1 year was lower than previous estimates and, as these authors point out, may limit the effectiveness of the fecal occult blood test in colorectal cancer screening programs. The authors also speculate on the likelihood of finding a significant colorectal adenoma in patients with a negative fecal occult blood test. The implication that significant adenomas are unusual (<2%) in patients with a negative fecal occult blood test is unfounded and misleading. Most patients with a
Lieberman D. Hemoccult Screening and Colorectal Neoplasms. Ann Intern Med. 1990;112:880–881. doi: 10.7326/0003-4819-112-11-880
Download citation file:
Published: Ann Intern Med. 1990;112(11):880-881.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use